Schierman L W, McBride R A
Avian Dis. 1979 Jan-Mar;23(1):47-56.
A study was made of the effects of vaccination with turkey herpesvirus on the growth of tumors following inoculation of lymphoma cells induced by Marek's disease virus (MDV). The cells used were from a transplantable MDV-induced lymphoid tumor (MDT-198) maintained by passaging in syngeneic hosts. Vaccination did not prevent progressive tumor growth or alter subsequent mortality among syngeneic recipients of MDT-198 cells. With allogeneic recipients, however, vaccination had a significant protective effect in that progressive tumor growth and mortality were markedly lowered. Both development of visceral lymphomas and atrophy of thymus and bursa were found at necropsy in both syngeneic and allogeneic hosts when progressive tumor growth occurred at the site of inoculation. The results suggest that it is unlikely that the primary and effective component of turkey-herpesvirus-induced protection against Marek's disease is directed against Marek's-disease-tumor-specific antigens.
研究了用火鸡疱疹病毒接种对接种马立克氏病病毒(MDV)诱导的淋巴瘤细胞后肿瘤生长的影响。所用细胞来自通过在同基因宿主中传代维持的可移植MDV诱导的淋巴肿瘤(MDT - 198)。接种疫苗并不能阻止同基因MDT - 198细胞受体中的肿瘤进行性生长,也不能改变随后的死亡率。然而,对于异基因受体,接种疫苗具有显著的保护作用,因为肿瘤的进行性生长和死亡率明显降低。当接种部位出现肿瘤进行性生长时,在同基因和异基因宿主的尸检中均发现了内脏淋巴瘤的发展以及胸腺和法氏囊的萎缩。结果表明,火鸡疱疹病毒诱导的针对马立克氏病的主要和有效保护成分不太可能针对马立克氏病肿瘤特异性抗原。